Insider Cluster (2 insiders) ·Filed May 26, 2026

DXCM

DEXCOM INC
NEUTRAL
Impact 2/10
Horizondays Processed4mo ago
Insider cluster: 2 insiders, $2.0M total
Actionable Insight • Neutral

The dollar value is too small to move the stock. Monitor for any larger insider activity or a follow-up Form 144 that might indicate a forward sale plan. No trade recommendation warranted — treat as noise.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
DXCM ▲ +28.46% at T+60d
NEUTRAL call ✓ call won +28.46% · α vs SPY +26.84% · entry $70.17 → $90.14
Entry anchored
May 26, 2026
via day open
T+1d
+2.99%
call +2.99% · α +2.44%
$72.27
settled 4mo ago
T+5d
+3.61%
call +3.61% · α +3.14%
$72.70
settled 4mo ago
T+20d
-0.60%
call -0.60% · α +1.69%
$69.75
settled 3mo ago
T+60d
+28.46%
call +28.46% · α +26.84%
$90.14
settled 6w ago

Price Chart

Loading chart...

Executive Summary

Two Dexcom insiders, including Executive Chair Kevin Sayer, sold a combined $2.03M in stock over a 7-day window. The largest sale was Sayer's open-market sale of $1.93M on May 21 at $72/share. The $2.03M total is ~0.007% of Dexcom's $27.8B market cap — well below the 0.1% materiality threshold. The sales appear routine and liquidity-driven, not indicative of a material bearish view.

Key Financial Metrics

Direction
selling
Total Value
$2.0M
Insiders
2

Key Facts

  • Executive Chair Kevin Sayer sold 26,759 shares for $1.93M on May 21 at $72.00
  • EVP/Chief Legal Officer Michael Jon Brown sold ~1,700 shares for ~$102K on May 15 at $59.91
  • Total cluster value of $2.03M represents ~0.007% of Dexcom's $27.8B market cap
  • Both sales are open-market transactions, no insider buying in the cluster

Financial Impact

Total insider selling of $2.03M — economically negligible relative to $27.8B market cap

Risk Factors

  • Insider selling could increase if share price continues to appreciate
  • No bearish signal from current cluster — risk of over-interpreting low-value sales

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
86% bullish (37 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-DXCM-1779826770039
11 reports for DXCM
Performance horizon
Filters
Rows
Reports for DXCM — sortable, filterable
TypeNow
Sep 14, 2026
17d ago
8-K
NEUTRAL ★ 2/10
$86.45 $89.53▲ +3.56%▲ +1.44%$85.36 (−1.26%)
Aug 28, 2026
4w ago
Insider Cluster
NEUTRAL ★ 2/10
$91.06 $84.53▼ −7.17%▼ −7.03%$85.36 (−6.26%)
Aug 24, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$91.06 $91.06· 0.00%▼ −0.47%$85.36 (−6.26%)
Aug 17, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$88.76 $91.06▲ +2.59%▲ +3.78%$85.36 (−3.83%)
Jul 21, 2026
10w ago
Insider Cluster
NEUTRAL ★ 2/10
$71.43 $75.14▲ +5.19%▲ +7.60%$85.36 (+19.50%)
Jun 17, 2026
15w ago
Insider Cluster
NEUTRAL ★ 2/10
$72.47 $68.65▼ −5.27%▼ −3.61%$85.36 (+17.79%)
May 26, 2026
18w ago
Insider Cluster
NEUTRAL ★ 3/10
$70.17 $73.45▲ +4.67%▲ +3.46%$85.36 (+21.64%)
May 26, 2026
18w ago
Insider Cluster
NEUTRAL ★ 2/10
$70.17 $72.70▲ +3.61%▲ +3.14%$85.36 (+21.64%)
May 19, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$71.24 $72.27▲ +1.45%▼ −0.36%$85.36 (+19.82%)
Apr 15, 2026
24w ago
DEFA14A
NEUTRAL ★ 2/10
$61.01 $62.68▲ +2.74%▲ +1.75%$85.36 (+39.90%)
Showing 10 of 11

US Market Status

Market Closed — Opens Mon (65h 2m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published May 26, 2026